The UNC Lineberger Comprehensive Cancer Center and The University of North Carolina School of Medicine seek an exceptional physician scientist to lead our efforts in Cancer Precision Medicine. Over the past decade, UNC Lineberger emerged as a leader in the NCI TCGA effort. We have developed an infrastructure for sequencing, bioinformatic analyses, molecular pathology, and their application to patient care through a molecular tumor board. We now search for a translational scientist to head the clinical aspects of an expanding program. We are currently developing novel CLIA assays as well as methodologies to perform genomic analysis to identify somatic and germline mutations, evaluate transcriptome expression using RNA-sequencing, and characterize immune repertoires using next generation sequencing. We have developed robust applications for data analysis and anticipate that the person leading this group will utilize these other tools they develop to enhance personalized care for cancer patients and prospective clinical trials. The position is tenure track and open to those at all ranks. Applicants should provide evidence of a strong record of clinical, translational or basic approaches to broad areas of genetics, genomics, gene expression, epigenetics, proteomics, tumor immunology, and/or precision early cancer detection and prevention. Applications will be reviewed by search committee chair Chuck Perou, PhD and the committee beginning January 1, 2018 and until the position is filled.